Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05142358 · ClinicalTrials.gov registry record · NA
A Prospective Study to Evaluate Continuous Positive Airway Pressure Devices to Reduce Pulmonary Dose
A NA study of Lung Cancer and Left Sided Breast Cancer, sponsored by Case Comprehensive Cancer Center.
- Completed
- Registry status
- NA
- Development phase
- 8
- Enrollment target
- 1
- Study location
NCT05142358: Completed NA study of Lung Cancer and Left Sided Breast Cancer, sponsored by Case Comprehensive Cancer Center.
NCT05142358 is a NA study of Lung Cancer and Left Sided Breast Cancer that has completed, run by Case Comprehensive Cancer Center. The registered enrollment target is 8 participants, below the 936-participant average among 409 other Lung Cancer trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05142358, a NA study of Lung Cancer and Left Sided Breast Cancer, has completed, sponsored by Case Comprehensive Cancer Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 8 participants
- Enrollment target
- 1
- Study location
Study Summary
Data collection and assessment on patients with left-sided breast cancer or undergoing lung stereotactic body radiation therapy (SBRT) utilizing continuous positive airway pressure (CPAP) devices.
Primary Outcome
The primary objective will be to assess changes in lung dosimetry V5 on the affected side when using CPAP compared to free breathing will be measured in percentages.
Conditions Studied
Interventions
- DEVICE Continuous Positive Airway Pressure
- OTHER Deep inspiratory breath hold
- OTHER Free Breath
Study Locations (1)
Ohio
- Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Cancer Center - Cleveland
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 8 participants |
| Start Date | 2022-10-19 |
| Est. Completion | 2026-01-28 |
| Phase | NA |
What the finished NCT05142358 record still lists
NCT05142358 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 8 participants, a relatively small participant target, below the 936-participant average among 409 other Lung Cancer trials with a reported enrollment target (99% lower).
The record links to 2 conditions, with Lung Cancer appearing as the primary indexed condition, and to 3 interventions - of which Continuous Positive Airway Pressure is the first listed.
NCT05142358 reports a single indexed study location in Ohio.
Frequently Asked Questions
What is clinical trial NCT05142358 about?
NCT05142358 is a clinical study titled "A Prospective Study to Evaluate Continuous Positive Airway Pressure Devices to Reduce Pulmonary Dose". Data collection and assessment on patients with left-sided breast cancer or undergoing lung stereotactic body radiation therapy (SBRT) utilizing continuous positive airway pressure (CPAP) devices.
What is the current status of trial NCT05142358?
This trial is currently completed. It is a NA study. The enrollment target is 8 participants. The study started on 2022-10-19. Estimated completion is 2026-01-28.
What conditions does trial NCT05142358 study?
This clinical trial studies the following conditions: Lung Cancer, Left Sided Breast Cancer.
What interventions are being tested in trial NCT05142358?
The interventions under investigation include: Continuous Positive Airway Pressure (DEVICE), Deep inspiratory breath hold (OTHER), Free Breath (OTHER).
Who is sponsoring clinical trial NCT05142358?
This trial is sponsored by Case Comprehensive Cancer Center, which has 407 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05142358 being conducted?
This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Lung Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05142358's enrollment target sits among peer trials
8 399th of 409 higher than 9 of 409 other Lung Cancer trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Lung Cancer trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Lung B.A.S.E.S. 4 Life Mobile Low-dose Computed Tomography (LDCT) Screening: Ages 40-54
RECRUITING · NA
-
Lung Cancer Screening in High-risk Black Individuals
RECRUITING · NA
-
A Patient and Provider Intervention to Address Health Disparities in Lung Cancer Screening
RECRUITING · NA
-
Exercise as Maintenance Therapy in Advanced Lung Cancer
RECRUITING · NA
-
Improving Care for Rural Patients With Solid Tumors
RECRUITING · NA
-
Stereotactic Magnetic Resonance Guided Radiation Therapy
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI